Treatment-free remission after thrombopoietin receptor agonist discontinuation in patients with newly diagnosed immune thrombocytopenia: an observational retrospective analysis in real-world clinical practice.

In conclusion, patients with newly diagnosed ITP who achieve sustained response should consider discontinuation of TPO-RAs. PMID: 32476083 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32476083?dopt=Abstract

Source: International Journal of Hematology - May 30, 2020 Category: Hematology Authors: Iino M, Sakamoto Y, Sato T Tags: Int J Hematol Source Type: research

More News: Hematology | Study | Thrombocytopenia